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Abstract
Malignant melanoma is a cancer of the skin arising in the melanocytes. We present a mathematical model of melanoma
invasion into healthy tissue with an immune response. We use this model as a framework with which to investigate primary
tumor invasion and treatment by surgical excision. We observe that the presence of immune cells can destroy tumors, hold
them to minimal expansion, or, through the production of angiogenic factors, induce tumorigenic expansion. We also find
that the tumor–immune system dynamic is critically important in determining the likelihood and extent of tumor regrowth
following resection. We find that small metastatic lesions distal to the primary tumor mass can be held to a minimal size via
the immune interaction with the larger primary tumor. Numerical experiments further suggest that metastatic disease is
optimally suppressed by immune activation when the primary tumor is moderately, rather than minimally, metastatic.
Furthermore, satellite lesions can become aggressively tumorigenic upon removal of the primary tumor and its associated
immune tissue. This can lead to recurrence where total cancer mass increases more quickly than in primary tumor invasion,
representing a clinically more dangerous disease state. These results are in line with clinical case studies involving resection
of a primary melanoma followed by recurrence in local metastases.
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Introduction
Melanoma, the most dangerous form of skin cancer, arises in
the melanocytes and progresses through two well-defined clinical
stages. Following a period of radial growth in the epidermis,
melanomas may switch to malignant, vertical growth melanoma
(VGM) [1]. This switch generally occurs following the onset of
angiogenesis and penetration of the basement membrane (BM)
separating the dermis and epidermis [2]. These processes are
tightly coupled in melanomas [2,3].
Angiogenesis is induced primarily by the release of angiogenic
factors by melanoma cells and associated stromal cells and through
the restructuring of the extracellular matrix (ECM) that occurs in
concert with invasion [4]. Angiogenesis of lymphatic vessels
(lymphangiogenesis) also occurs in melanomas and plays a role in
lymphatic metastasis [5]. Melanomas are known to produce a
number of angiogenic cytokines, the most prominent being
vascular endothelial growth factor (VEGF) and basic fibroblast
growth factor (bFGF) [2]. VEGF is overexpressed both constitu-
tively and in response to hypoxia [6].
Although some angiogenesis may occur before penetration of
the basement membrane, intense angiogenesis requires ECM
remodeling, which in turn requires the cooperation of stromal
cells. Even if the tumor is releasing large amounts of VEGF, most
of it is sequestered in the ECM [7]. Fibroblast recruitment is
essential for the angiogenic switch. Once recruited by platelet
derived growth factor (PDGF) and other cytokines, fibroblasts
begin producing ECM degrading matrix metalloproteases (MMPs)
[8]. Matrix degradation releases large amounts of sequestered
angiogenic growth factors, including VEGF, and eases the
penetration of new capillaries [7,8]. MMPs also aid in recruiting
stromal cells involved in angiogenesis. MMP-9 induces prolifera-
tion and motility of endothelial precursor cells (EPCs) in the bone
marrow [8], and MMP-2 recruits VEGF expressing macrophages
and leukocytes [9].
Endothelial cells are the predominant cell type in the formation
of new vasculature. Endothelial cell migration into the tumoral
region is essential for angiogenesis and is facilitated by MMP
mediated matrix remodeling [9] and migration up chemotactic
and haptotactic gradients [10]. The tumoral vasculature incorpo-
rates epithelial cells from the existing vasculature as well as
circulating EPCs. The latter are likely important in sustained,
intense angiogenesis as they provide a much larger pool of
endothelial cells than the native tissue alone can provide [11,12].
Chemotaxis occurs in response to a number of factors, the most
important being VEGF. Growing epithelial sprouts extend
filopodia, indicating that they, like epithelial cells, can respond
to a VEGF gradient [10].
The immune system is able to effectively mobilize against tumor
invasion. This occurs mainly through direct tumoricidal action by
natural killer (NK) cells and phagocytes, such as macrophages, and
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microenvironment is strongly immunosuppressive [13], and while
the immune response can hinder invasion, tumor-associated
lymphocytes and macrophages have been observed secreting
growth and angiogenic factors that may aid in tumor invasion
[7,13,14].
Melanoma has a strong tendency to metastasize, with most
metastases occurring in the skin, lymph nodes, and lungs [5].
Following resection of the primary lesion, cancer can recur locally.
This is often due to growth in local satellite metastases and is not
caused by incomplete resection [15]. Removal of the primary
tumor can stimulate growth in previously dormant metastases
[7,16,17]. Metastatic melanoma has a very poor clinical prognosis
and is largely unresponsive to existing therapies [1].
In this paper we develop a spatially explicit model using partial
differential equations (PDEs) to capture the dynamics of
melanoma invasion in the skin. We first present a basic model
that does not consider an immune response and examine tumor
invasion in a cylindrical section of skin. Then we extend this model
to include a cellular immune response and carry out a number of
numerical experiments using this extended model. In these, we
examine the possible dynamics of tumor invasion under different
levels of immune response. We develop a method to realistically
model the stochastic process of local metastatic spread, and
surgical treatment is simulated in both locally metastasizing and
non-metastasizing melanomas. These simulations are motivated
by a clinical case where, following resection of a primary
melanoma, widespread recurrence was seen in local satellite
metastases [17].
Based on our simulations we make several observations and
predictions. First we observe that angiogenesis is strongly
tumorigenic, which is very well known from previous experimental
and theoretical work. In accordance with the biological observa-
tions in [6], we find that the production of angiogenic factors by
melanoma cells in response to hypoxia is insufficient to induce
angiogenesis and vertical growth; constitutive production of such
factors is needed. These results validate the basic construction of
the complex model.
We show that the immune response can either aid or inhibit
tumor progression; the outcome depends on the balance between
angiogenic factors released by immune cells and the growth-
inhibitory and cytotoxic effects of the same immune cells. We also
make several predictions concerning treatment and metastasis. We
observe that a relatively small safety margin is necessary to remove
all primary tumor material and prevent local recurrence due to
‘‘local persistence’’ (as defined in [15]). In the case of a tumor
spawning satellite metastases, we predict that the immune response
directed against a primary tumor can suppress these metastases ‘‘in
passing.’’ The removal of the primary tumor also removes most of
this immune response, allowing the cancer to recur through the
growth of these previously suppressed metastases. Thus, local
recurrence in previously dormant satellite metastases seen in
clinical cases [17,15] can be explained as a consequence of
immune disruption.
Methods
Mathematical Model
We propose a spatially explicit model of melanoma invasion in
the skin, formulated in terms of cell densities. We first present the
full system with a detailed derivation of the governing equation for
each variable. We then describe the model geometry and
boundary conditions.
The basic model considers seven variables:
1. c r,z,t ðÞ ~tumor cell density tumor cells TCs ðÞ mm{3   
2. h r,z,t ðÞ ~healthy cell density healthy cells HCs ðÞ mm{3   
3. v r,z,t ðÞ ~tumor angiogenic factor TAF ðÞ density
grams mm{3   
4. b r,z,t ðÞ ~blood vessel endothelial cell density endothelial ð
cells ECs ðÞ mm{3Þ
5. d r,z,t ðÞ ~necrotic debris density tumor cells ð
TCs ðÞ mm{3Þ
6. r r,z,t ðÞ ~partial pressure of oxygen mmHg ðÞ
7. l r,z,t ðÞ ~basement membrane basal lamina ðÞ density
grams mm{3   
The basic assumptions we use to derive the model follow
1. Cell motility is achieved according to Fick’s Law, which yields a
diffusion term. Cancer cell motility additionally depends upon
contact with other cancer cells and oxygen concentration.
2. Oxygen is the limiting nutrient and diffuses into the skin from
the skin surface and a subcutaneous vascular bed [18].
3. Proliferation of both healthy and cancerous cells is mediated by
the amount of space available and the concentration of oxygen
[19].
4. Cancer cell death is mediated by oxygen concentration, and
cancer cells that die in response to hypoxic stress become
necrotic debris [19].
5. Cancer cells produce angiogenic factors both constitutively and
in response to hypoxia [20,6].
6. Endothelial cells migrate into the system in response to
angiogenic factors and form the tumor vasculature, which
supplies additional oxygen [10,12].
7. A basement membrane separates the epidermis from the
dermis and restricts cell migration [2].
Author Summary
Melanoma is a deadly skin cancer that invades into the
dermis and metastasizes into the surrounding tissue. In
clinical cases, surgical excision of the primary tumor has
led to widespread and accelerated growth in metastases.
We develop a mathematical model describing the basic
process of melanoma invasion, metastatic spread, and the
anti-tumor immune response. This model is formulated
using partial differential equations that describe the spatial
and temporal evolution of a number of different cellular
populations, and it uses a realistic skin geometry. Using
simulations, we examine the importance of the immune
response when a primary tumor is spawning satellite
metastases. We find that local metastases can be
suppressed by the immune response directed against
the primary tumor, but grow aggressively following
surgical treatment. We also find that moderately meta-
static tumors optimally activate the local immune response
against disseminated disease, and in this case tumor
excision may have profound effects on metastatic growth.
We conclude that surgical perturbation of the immune
response controlling local metastases is one mechanism by
which cancer can recur. This could have implications as to
the appropriate clinical management of melanomas and
other solid tumors.
Tumor-Immune Interaction in a Model of Melanoma
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Tumor cells. Cancer cell motility is achieved through
density-dependent diffusion proportional to oxygen
concentration. This is based on the assumption that cancer cell
motility requires contact with other malignant cells as well as
oxygen sufficient to provide the energy required for migration.
The density dependent term is similar to that used by Tohya
et al. in a model of basal cell carcinoma [21]. However, in their
formulation motility increases linearly with nutrient (i.e. oxygen)
concentration. We assume that while low oxygen concentration
inhibits mobility, there is little or no benefit to increasing oxygen
concentration beyond some sufficiently large concentration. Note
that the same parameter, h1, is used to control oxygen dependence
for both motility and growth. The coefficient Dc determines how
quickly cancer cells diffuse in this fashion and can be considered a
general measure of tumor invasiveness and cell motility. For
example, loss of keratinocyte mediated control over melanomas
would increase Dc, as would an increase in the expression of a
number of surface integrins that increase motility and reduce
dependence on neighboring cells.
The Heaviside term, HL T{l ðÞ , inhibits cancer cell motility in
any region where the basement membrane (BM) density is above
the threshold LT. This is biologically well-founded, as cancer cells
cannot generally cross the basement membrane unless it is
sufficiently degraded.
We assume that cancer cell growth is dependent upon both the
local cell density and oxygen concentration. Dependence on
density is approximated by a logistic growth term with maximum
per capita growth rate ac. The associated Hill function implies that
growth is inhibited when oxygen concentration is low; h1 is the
partial pressure of oxygen (PO2) at which half-maximal growth
occurs. This Hill function form is widely used in the model, and it
has been used in many other models of cancer invasion [22,23].
We assume that cancer cells also undergo apoptosis in response
to extreme hypoxia at maximum rate ac. Similar to the term
governing growth inhibition, h2 is the PO2 at which half-maximal
death occurs. We also assume that malignantly transformed cells
suppress normal apoptosis and hence do not experience normal
turnover.
Healthy cells. Healthy cells are a generic type representing
both the epidermal keratinocytes and dermal fibroblasts that make
up most of the skin. We assume all healthy cell motility is due to
simple diffusion and that cells cannot cross regions of high
basement membrane density. Healthy cells grow logistically with
carrying capacity KH and turn over regularly at rate bh. Like
cancerous cells, the birth and death of healthy cells is mediated by
hypoxia; the growth inhibiting and apoptosis inducing terms are
similar to those included in the equation for cancer cells.
Tumor Angiogenic Factor (TAF). TAF can be viewed as an
aggregation of those angiogenic factors released by melanomas.
The most important of these is VEGF, and wherever possible (e.g.
in parametrization) we treat TAF as though it were VEGF. TAF
diffuses by simple diffusion and degrades at rate bv. Melanoma
cells produce TAF both in response to hypoxia and constitutively.
This production varies widely among melanoma strains with the
constitutive production typically being the more important source
[20,6]. The maximum rate of TAF expression in response to
hypoxia is given by av, and the Hill function causes this expression
to be half-maximal when PO2 is equal to h1. Tumor cells also
Tumor-Immune Interaction in a Model of Melanoma
PLoS Computational Biology | www.ploscompbiol.org 3 April 2009 | Volume 5 | Issue 4 | e1000362produce TAF constitutively at rate cv. We also include a term
representing the uptake of TAF by endothelial cells. This uptake is
proportional to the stimulation of ECs by TAF, which is
represented by the v= Qvzv ðÞ term.
Endothelial cells. Endothelial cells (ECs) are the primary
cell type involved in capillary construction. We do not explicitly
model the tumor vascular network, but instead assume that the
density of microvessels is directly proportional to endothelial
cell density. Therefore, we only consider the averaged
microvessel density and omit the details of capillary
construction, which is spatially complex and marked by local
irregularities. Since our model considers tumor invasion at the
macro-scale, this simplification has a minimal effect on the
dynamics.
In this model we assume EC motility is achieved only through
simple diffusion. Most models of angiogenesis also consider
chemotaxis in response to a TAF gradient [24]. However, in our
model geometry an influx of ECs from the vasculature is induced
by high TAF concentration. Upon entering the domain, the spatial
scale on which they must migrate is only about 1 mm in the
vertical domain. Therefore, given the small spatial scale, we
conclude that chemotaxis can be neglected in this geometry.
Simulations have also confirmed that results are not significantly
affected by this omission.
EC proliferation in response to TAF appears to occur mainly
when EC density is low. This occurs at the leading edge of a
migratory EC front and in existing microvasculature that has been
destabilized by TAF to the point that the ECs are pulled away
from each other [25]. Therefore, we only allow EC proliferation if
the density is below the threshold value BT. If EC density is below
this threshold ECs proliferate in response to TAF. The magnitude
of response is controlled by the Hill function v= Qvzv ðÞ , where Qv
is the value at which half-maximal proliferation is observed. Note
that this is the same Hill function as that governing TAF uptake by
ECs due to our (implicit) assumption that uptake is translated into
growth.
ECs have been observed to undergo apoptosis when VEGF
levels are below a certain critical value [25,26]. Therefore, in the
model, instead of proliferating, ECs die at maximum rate av
whenever TAF density is below the threshold value VT. There is
also a baseline EC death rate bb.
Necrotic debris. Those cancer cells that die become necrotic
debris, hence the addition of the cancer cell death term to the right
side of the equation. We assume that normal homeostatic
mechanisms in the skin prevent healthy cells from contributing
significantly to necrotic material. This debris is assumed to
disperse at a low rate through simple diffusion and degrade at
some small rate bd.
Oxygen. Oxygen diffuses through the skin where it is
consumed by both melanomas and normal skin cells, and it is
supplied by the tumor vasculature represented by endothelial cell
density. Oxygen diffuses by simple diffusion with the diffusion
coefficient Dr. The rate of diffusion varies with skin depth: it is
small for the upper epidermis and large for the dermis [27].
The source term represents the supply of oxygen from the
tumor vasculature and is modeled according to the principle of
solute transport as given in [28]. We consider only diffusion across
the capillary and omit any convective transport. Oxygen diffusion
is proportional to the PO2 difference between the interstitium and
the capillary. The total microvessel surface area corresponding to a
single endothelial cell is given by Ab, and P is the capillary
permeability coefficient. We make the additional assumption that
oxygen is only supplied by, and not lost to, the tumor vasculature,
yielding the Heaviside term.
Oxygen is consumed by melanomas and normal skin cells.
Here, we include the cancer cell birth term as f1. The baseline rate
of oxygen consumption in normal skin, u0, is a constant given by
[18]. The baseline rate of oxygen consumption per melanoma cell
beyond that consumed by a healthy cell is ms, and u1 is the oxygen
consumed by melanoma proliferation. We use Tristan et al. [29] as
a guide in deriving this term. Adapting their notation, per capita
cell growth m is given as:
m~YXS
S
c
{ms
  
Where S is oxygen consumption, ms is maintenance oxygen
consumption as noted above, and YXS is the yield of cells per unit
oxygen, given as:
YXS~
mmax
Vmax{ms
mmax is the maximum cell growth rate, and Vmax is the maximum
oxygen consumption rate. In our model m~f1=c,a sf1 is the total
growth for cancer cells and mmax~ac. This leads to the following
expression for melanoma oxygen consumption:
S~f1
Vmax{ms
ac
  
zcms
Thus, we arrive at u1~f1 Vmax{ms ðÞ =ac.
Finally, if no is oxygen present, then clearly none can be
consumed. Therefore,
r
rz1
is included to force oxygen consump-
tion to zero if none is present.
Basement membrane. The basement membrane (BM) is
the most important geometric feature of the skin and has been
included. It is a static ‘‘wall’’ across which cancer (and healthy)
cells cannot cross. We assume the presence of endothelial cells
degrades the basement membrane at rate bl; the l= hlzl ðÞ term
causes degradation to go to zero as membrane density goes to
zero. This term is similar to that used in [23] to represent ECM
degradation by cancer cells.
This assumption can be justified biologically as the switch from
radial to vertical growth appears to require both the degradation
of the BM and angiogenesis, and the two processes are tightly
coupled [3]. Migration of ECs degrades the membrane, and
matrix metalloproteinases (MMPs) that degrade the membrane
must be released along with angiogenic factors to allow EC
migration [9]. MMP activity is also necessary to mobilize
endothelial precursor cells from the bone marrow [8]. Thus, the
EC response to TAF can be thought to encapsulate all
mechanisms by which the BM is degraded.
Geometry
As our model is intended to capture the process of primary
melanoma invasion in the skin we must build a reasonable
approximation to this geometry. Therefore, we generally consider
a three-dimensional domain using cylindrical coordinates –
r,h,z ðÞ . We furthermore assume radial symmetry, eliminating
dependence on h and reducing our consideration to only two
independent spatial variables - r,z ðÞ .
Considering a cylindrical section of skin, let 0ƒrƒR and
0ƒzƒZ, where the z-axis is directed downward from the surface
of the skin. We assume that at z~Z (i.e. the base of the skin
segment) there exists a vascular bed. Oxygen is supplied by this
Tumor-Immune Interaction in a Model of Melanoma
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are used to hold oxygen concentration constant at the skin surface
(z~0) and at the vasculature (z~Z). Also, the vascular bed is the
source for all endothelial cells entering the skin section. In response
to TAF, existing vasculature is destabilized and endothelial cells
begin migrating up the TAF gradient. Circulating endothelial
precursor cells can also be recruited by TAF and enter the skin
from the vascular bed. Therefore, we use a Neumann boundary
condition to represent an influx of endothelial cells in response to
TAF from both these sources.
Finally, the basement membrane separates the epidermis and
dermis, serving as a barrier to migration for most cell types. The
basement membrane is modeled using initial conditions in
simulations - a thin strip of membrane is thought to exist at a
depth of approximately 0.15 mm. A simple schematic of the
modeled geometry is shown in Figure 1.
Boundary Conditions
All boundary conditions are no-flux with several exceptions for
oxygen and endothelial cells. The Dirichlet boundary conditions
for oxygen are 150 mmHG for the skin surface [18] and
90 mmHg for the vasculature [30]:
r r,0,t ðÞ ~150
r r,Z,t ðÞ ~90
We also provide for an influx of ECs from the vascular bed and
circulation through a Neumann boundary condition at Z as
follows:
Lb r,Z,t ðÞ
Lz
~N
v
vzQv
  
The maximum EC influx is N, and Qv is the TAF concentration
at which half-maximal EC stimulation occurs.
Parametrization for the Basic Model
While this model contains a large number of parameters, we can
make at least a reasonable order of magnitude estimate for all of
them from empirical biological data.
A wide range of population doubling times has been observed
for different melanoma lines, with more advanced tumors typically
having higher growth rates. Doubling times range between
approximately 1 and 4 days [31,32]. We always assume that the
maximum death rate is roughly the same as the maximum growth
rate. The maximum density of melanoma lesions also varies
widely. A range from 1.0610
5–5.0610
5 TC mm
23 for several
tumor strains is given in [33].
The linear diffusion coefficient for human keratinocytes was
measured between .002 and .07 mm
2 day
21 in [34]. Assuming
that melanoma cells achieve a similar rate of diffusion at
maximum density yields Dc in the range 7.0610
27–4.0610
29,
using the range of densities reported in [33].
In [35], a threshold for hypoxia of 10 mmHg is given, with 5–
7.5 mmHg considered moderate hypoxia and PO2ƒ2:5 mmHg
considered severe. We estimate our parameters governing the
sensitivity of growth and death to PO2 using these values as
guidelines. Moreover, we generally assume that healthy cells are
more sensitive to hypoxia than cancerous cells. We also assume
that production of TAF is proportional to growth inhibition due to
Figure 1. A simple schematic of the modeled geometry. The epidermis is separated from the dermis by a sheet of basement membrane. At the
base of the dermis is a vascular bed from which all endothelial cells migrate. Oxygen diffuses into the domain from the vascular bed and at the skin
surface. The melanoma tumor originates in the epidermis. All other tissue is initially healthy cells.
doi:10.1371/journal.pcbi.1000362.g001
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functions.
In a tissue scaffold model the diffusion coefficient for VEGF has
been measured as Dv~6:048 mm2 day{1 and the degradation
rate as bv~19:96 day{1 [36]. However, using the relation given
in [37] with a molecular weight of 45 kDa for VEGF gives
Dv~0:497 mm2 day{1, about an order of magnitude lower.
Maximum rates of constitutive and hypoxic VEGF expression for
several melanoma lines are given in [20,6].
Using data from [38], the growth rate for bovine endothelial
cells is calculated as av~:30{:90. Each endothelial cell
corresponds to approximately 5 mm of vessel [22]. Mean
vessel diameter for melanoma xenografts varies between
9.5 and 14.6 mm in [39]. This gives
Ab~1:492|10{4{2:293|10{4 mm2 EC
{1 with a mean value
of 1.893610
24. Measured values for the capillary permeability
coefficient for oxygen are reported to range between 8.64 mm
day
21 and 6.74610
4 mm day
21, depending on the tissue type
[40].
The baseline oxygen consumption rate, u0, is given in [18]. A
number of values for Vmax for different cells are given in [18]; we
determine a maximum Vmax~6:68 mmHg TC
{1 day{1.
All parameters and values with references (if applicable) are
given in Table 1.
Model Extension - Cellular Immune Response
We extend the model to include a class of immune cells that are
directly cytotoxic to cancer cells. The most important of these cells
are macrophages, dendritic cells (DCs), natural killer cells (NKs),
and cytotoxic T cells (TCs). We do not consider the humoral (i.e.
antibody generating) immune response.
Melanomas secrete inflammatory cytokines that attract circu-
lating monocytes to the site of invasion. These monocytes can
differentiate into macrophages or dendritic cells [13]. Macro-
phages and DCs are both important phagocytes, capable of
engulfing tumor cells as well as fragments of necrotic debris.
Macrophages are frequently observed both infiltrating the tumor
mass and in the peritumoral region of melanomas. Interestingly,
these macrophages can be either harmful or helpful to tumor
development. Although macrophages have a cytotoxic effect on
tumor cells, tumor-associated macrophages release a number of
angiogenic factors, including VEGF, bFGF, IL-8, and TNF-a that
can aid in tumor progression [41]. In a mouse model by Nesbit et
al. [14], modest expression of monocyte chemoattractant protein-1
(MCP-1) in melanomas attracted macrophages that proceeded to
aid the tumor through release of angiogenic factors. However,
high expression led to massive macrophage infiltration that
destroyed the tumor within days.
Natural killers do not need any education to recognize and
destroy neoplastic cells. On encountering aberrant cells NKs can
initiate a large scale immune response through the release of
cytokines that recruit other effector immune cells, the most
important being tumor necrosis factor c (TNF-c) [7].
A strong response by effector immune cells is probably more
harmful to the tumor than helpful. The presence of tumor-
infiltrating lymphocytes (TILs) has been associated with a good
clinical prognosis in a number of cancers. Patient survival is 1.5 to
3 times longer in melanoma patients with high numbers of TILs
compared to patients with few TILs [7]. Here we present an
extension to the basic model that considers effector cell-tumor
interactions. Two new variables are introduced:
1. m x,t ðÞ ~m r,z,t ðÞ ~cytotoxic immune cell density
immune cells ICs ðÞ mm{3   
2. a x,t ðÞ ~a r,z,t ðÞ ~00immune attracting factor00 IAF ðÞ
density grams mm{3   
Similar to the TAF formulation, a is a generic aggregation of all
chemokines that attract macrophages and other immune cells
which we refer to as immune attracting factor (IAF). These factors
are primarily MCP-1 and TNF-c. m is an aggregation of all
cytotoxic effector cells. This aggregate type most closely resembles
macrophages and natural killers, as it is cytotoxic to tumor cells
and clears necrotic debris. Like natural killer cells, it also has the
ability to initiate a larger immune response through secretion of
IAF.
We assume that ICs are attracted by IAF and are activated by
contact with either tumor cells or necrotic debris. Tumor cells
express IAF at a constant constitutive level. ICs express TAF and
IAF and have a cytotoxic effect on tumor cells. Contact with
tumor and dead cells is assumed to activate ICs. This activation
causes immune cells to express both TAF and IAF and increases
anti-tumor and debris cytotoxicity. Given that the tumor
microenvironment is often immunosuppressive and even directly
toxic to immune cells [7,13], we also assume that tumor cells have
a cytotoxic effect on ICs. Additionally, we assume that ICs can
devote energy either to debris cleanup or tumor cell destruction. A
cartoon of the modeled immune response is shown in Figure 2.
The equations governing ICs and IAF, as well as the modifications
to the equations for tumor cells, necrotic debris, and TAF, follow
(‘‘…’’ represents the original terms of the equation):
Lm
Lt
~Dm+2m{xm m+a ðÞ
|ﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄ}
chemotaxis
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d
ldzd
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IC cleanup
ð9Þ
C[ 0,1 ½  is the level of activation:
C~
wddzwcc
jzwddzwcc
  
IC mobility is achieved through simple diffusion and a
chemotactic response to IAF. C represents the level of activation
in response to contact with cancer cells and necrotic debris. wc and
wd weigh the relative ability of cancer cells and dead cells to
activate ICs, and j is the (weighted) cell density at which half-
maximal activation occurs. bm is normal IC turnover. Each cancer
cell kills ICs at maximum rate bK. Cancer cells generally do not
actually kill immune cells, but if we assume the hostility of the
Tumor-Immune Interaction in a Model of Melanoma
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then this formulation is a reasonable approximation. The
m= lmzm ðÞ term causes toxicity to saturate with sufficient IC
density. Generally, lm is be taken to be quite small, so that toxicity
is at nearly the maximum except at very low IC densities.
ICs are imagined to expend energy at some per capita rate t
which can be devoted either to debris cleanup or killing cancer
cells. The amount of energy devoted to either task is proportional
to the presence of debris and tumor cells as well as some inherent
bias toward one task or another. Energy devotion to debris
cleanup is measured as:
t
kd
kdzc
  
k is a parameter measuring the bias towards debris cleanup. We
suppose that t can be scaled in such a way as to measure
maximum rate of tumor cell destruction - tc, or dead cell
destruction - td. Modifying these further, tc0 and td0 are the
respective rates of destruction for a non-activated immune cell. tcA
and tdA are the the rates of destruction beyond tc0 and td0 for a
fully activated immune cell. Thus, we arrive at the additional
death terms for cancer cells: tc0ztcAC ðÞ m 1{ kd ðÞ = ð
kdzc ðÞ Þ c= lczc ðÞ ðÞ . The c= lczc ðÞ ðÞ terms cause toxicity to be
proportional to cell density, and lc is taken to be very small. The
additional death term for necrotic debris is similar.
We assume activated ICs produce TAF at a rate proportional to
the level activation, with a maximum of cvm. This assumption is
justified because, as already noted, tumor-associated macrophages
have been observed producing angiogenic factors, and it may be
that macrophages that have ingested tumor-derived antigens
produce very high levels of VEGF [7].
Table 1. Parameters and values for the basic model.
Param. Meaning Value Range Ref.
Dc Melanoma density dependent diffusion coeff. 7.0610
27–4.0610
29 [34,33]
ac Maximum TC growth rate .17–.69 day
21 [31,32]
h1 Measures sensitivity of TC growth to PO2 5–10 mmHg [35]
h2 Measures sensitivity of TC death to PO2 1–5 mmHg [35]
KC Total cell density above which TCs don’t prolif. 1.0610
5–5.0610
5 TC mm
23 [33]
Dh Healthy cell diffusion coefficient .002–.07 mm
2 day
21 [34]
ah Maximum healthy cell growth rate .1 day
21
bh Normal healthy cell turnover rate .03 day
21
KH Total cell density above which HCs don’t prolif. 1.0610
5–5.0610
5 HC mm
23
Dv TAF diffusion coefficient 0.497–6.048 mm
2 day
21 [37,36]
av Maximum hypoxic TC expression of TAF 2:4|10{15{1:1|10{14 gT C {1 day{1 [20,6]
cv Constitutive TC expression of TAF 6|10{16{1:5|10{14 gT C {1 day{1 [20,6]
mv Maximum per capita uptake of TAF by ECs 10{15 gE C {1 day{1
Qv TAF density of half maximal EC response 2:0|10{12 gm m {3 [25]
bv TAF degradation rate 19.96 day
21 [36]
Db EC diffusion coefficient .000864–.070848 mm
2 day
21 [42,43]
BT Critical density above which ECs don’t prolif. 1000 EC mm
23 [48,49]
ab Maximum EC growth/death rate .30–.90 day
21 [38]
VT TAF level below which ECs undergo apoptosis 5.0610
213 gm m
23 [25,26]
bb Baseline EC death .003–.005 day
21 [22]
N Maximum EC influx 1:0|104 EC mm{3 day{1
Dd Debris diffusion coefficient 1610
26 mm
2 day
21
bd Necrotic debris degradation rate 0.0–.01 day
21
Dr O2 diffusion coefficient 8/85/200 mm
2 day
21 [27]
Ab Capillary surface area per EC 1.492610
24–2.293610
24 mm
2 EC
21 [22,39]
P O2 capillary permeability coefficient 8.64–6.74610
4 mm day
21 [40]
PO2C Capillary PO2 30–40 mmHg [30]
u0 Baseline skin O2 consumption 1.2610
6 mmHg g
21 day
21 [18]
ms Melanoma maintenance O2 consum. beyond u0 0 [29]
Vmax Maximum melanoma O2 consum. beyond u0 #6.68 mmHg TC
21 day
21 [29]
bl Maximum rate of EC induced BM degradation 1.0610
24 gE C
21 day
21
LT Thresh. BM density above which migration inhibited .025 g mm
23
hl BM density of half-maximal degradation .01 g mm
23
doi:10.1371/journal.pcbi.1000362.t001
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the constant rate cac, and degrades at rate ba. ICs also produce
IAF at a rate proportional to the level of activation.
Boundary conditions are no-flux except for IAF. When IAF
concentration is high enough we expect an influx of ICs into the
domain, representing macrophage, NKs, and TCs migrating from
the circulation. The Neumann boundary condition used follows:
Lm r,Z,t ðÞ
Lz
~Q
a
azQa
  
The IAF density at which half-maximal IC migration occurs is
given by Qa, and Q is the maximum influx from the circulation.
Parametrization for the Immune Extension
We have derived a baseline set of values for most parameters
from empirical data. However, a wide range of values is allowed in
simulations for those parameters representing cytotoxicity, as these
are assumed to be quite variable among strains of melanoma.
We have been unable to find any estimates for the diffusion
coefficient for macrophages. However, given that measurements
for keratinocytes and endothelial cells fall within the same rough
Figure 2. A schematic of the modeled anti-tumor immune response. (1) Cancer cells produce factors that attract immune cells, primarily
macrophages and natural killers, to the tumor site. (2) In response to direct contact with either tumor or necrotic cells, immune cells are activated. (3)
These activated immune cells kill cancer cells and clear necrotic debris at an increased rate; they also produce both TAF and IAF, enhancing the
immune response while potentially inducing angiogenesis. (4) The tumor microenvironment is strongly immunosuppressive, and this is modeled by
assuming that direct contact with tumor cells is cytotoxic to immune cells.
doi:10.1371/journal.pcbi.1000362.g002
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[42,43], we can reasonably assume a similar range for immune
cells.
The molecular weight of MCP-1 was measured to be about
4 kDa in [44], although other authors have reported values of 8–
10 kDa [45]. Using the relation given in [37] yields
Da~1:536{3:054 mm2 day{1. We have been unable to find
any estimates on the half-life of MCP-1 either in tissue or in
plasma, but we assume it is on the order of several hours. This
gives bb~2:773{16:636 day{1 for a half-life of 1–6 hours.
Data on MCP-1 production by melanoma cells is given in [14],
from which we calculate cac~1:667|10{15{1:333|10{13
gT C
{1 day{1. We assume maximum expression by immune
cells is similar. We also assume that maximum expression of TAF
by immune cells is similar to the constitutive expression by
melanoma cells (see [20,6]).
The turnover rate for human natural killer cells has been
measured to be about 2 weeks [46], giving a maximum bm~:05.
However, since the overall natural killer population remains static,
the ‘‘effective’’ turnover rate is probably closer to 0.
To determine the rate at which immune cells kill tumor cells we
use data on phagocytosis in macrophages given in [47]. We
employ a simple ODE system considering macrophages (M),
macrophages that have ingested an antigen (MC), and a tracking
variable counting the total number of antigens ingested and
processed (K).
MzA
a
?MC
b
?M
Assuming the antigen level remains constant, this yields the ODE
system
dM
dt
~{aMzbMC ð10Þ
dMC
dt
~aM{bMC ð11Þ
dK
dt
~bMC ð12Þ
Solving numerically allows the slope of the kill tracking line (K)
to be calculated, yielding the rate at which macrophages destroy
antigen without the need to explicitly model antigen complex
populations in the full model. From [47], we estimate
a~5:28{14:4 day{1 and bƒ2:4 day{1, yielding a maximum
kill rate of 2.027 day
21, presumably for fully activated macro-
phages. Using a~5:28 and b~:01, we estimate the maximum
rate of destruction for inactivated macrophages to be about an
order of magnitude lower, at 0.218 day
21.
The parameters k, wc, and wd are scaling parameters, included
in the formulation for model flexibility. However, for a first
approximation we may simply set them all equal to 1. In the
absence of other data, and given that macrophage production of
MCP-1 is similar to melanoma production of VEGF, we assume
that Qa~Qv.
A tumor cell strain is considered immunoevasive when
parameter values are used that give low anti-tumor cytotoxicity
and/or a high cell density for activation. A cell strain is considered
immunosuppressive if it is highly cytotoxic to immune cells. All
immune extension parameters with values and references are
given in Table 2.
Results
Simulations of the Basic Model
All simulations have been run using a finite difference method
on the symmetric cylindrical domain described previously. We run
several simulations using the base model without the immune
response to characterize the basic dynamics. For biologically
realistic parameter values, the model produces realistic patterns of
invasion. Before the onset of angiogenesis, growth is restricted to
the epidermis. TAF expression by melanoma cells causes an influx
of endothelial cells into the domain, which leads to penetration of
the basement membrane and vascularization of the tumor within
several months. Following this angiogenic switch, density increases
and invasion spreads throughout the domain. Live cancer cell
density is highest at the skin surface and the vascular bed. Between
these boundaries the effects of oxygen consumption by prolifer-
ating cancer cells can be seen. Hypoxia is most pronounced near
the invasive edge, where oxygen demand is greatest. Necrotic
debris is initially concentrated in a roughly spherical core. As the
tumor continues to invade, this core expands as an annulus
following the invasive edge. Thus, the model predicts that in the
absence of an immune response a solid invasive tumor with a
necrotic core will form. Angiogenesis is predicted to be strongly
tumorigenic.
To thoroughly demonstrate the model results, a 3-D isosurface
of the evolution of three key variables, cancer cells, basement
membrane, and endothelial cells, over several months of invasion
is shown in Figure 3. A 2-D projection of the same simulation is
shown in Figure 4. Finally, a 1-D projection of variable densities at
the inner radius of the domain is shown in Figure 5.
A second set of simulations is performed in which the cancer cell
line does not produce TAF constitutively. In these simulations,
TAF production in response to hypoxia is not sufficient to induce
angiogenesis, and tumor growth is restricted to the epidermis.
Even when TAF production in response to hypoxia is set to the
highest value reported in [6] and maximum tumor cell density is
used, angiogenesis does not occur and growth remains radial. If
the same simulations are run with no hypoxic TAF production but
with the lowest rate of constitutive TAF production reported in [6]
then angiogenesis occurs, leading to an aggressive, vertically
invasive tumor. Therefore, we predict that the constitutive
production of TAF is much more important in melanoma of the
skin. This is in line with the conclusions made by Danielsen and
Rofstad in [6]. However, we note that constitutive production of
TAF by melanoma cells themselves may still be be unnecessary, as
stromal cells play a very important role in producing the
angiogenic factors and MMPs necessary for invasion, as discussed
previously. We can therefore conclude that TAF production in
response to hypoxia is insufficient to induce angiogenesis - TAF
must be produced by melanoma cells constitutively or supplied by
cooperating stromal cells.
Immune Response
In simulations of primary tumor invasion with an immune
response, tumor growth is generally slowed significantly. There
appear to be three possible eventual outcomes:
1. The tumor is completely destroyed.
2. A pseudo steady state is reached where the tumor ceases
growing, and immune cell infiltration levels remain constant.
3. The tumor succeeds in completely invading the domain.
Tumor-Immune Interaction in a Model of Melanoma
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space. The pattern of immune cell infiltration differs between
tumors that can be characterized as immunoevasive versus
immunosuppressive. In immunoevasive tumors, immune cell levels
are high in the core, while suppressive tumors result in a high
peritumoral concentration with little core presence.
We have also examined the effect of TAF in expression by
activated immune cells. This can cause a two-phase pattern of
growth, where the immune response initially holds the tumor to a
steady state within the epidermis. After a period of apparent
quiescence, immune-induced angiogenesis leads to a second phase
of more aggressive vertical growth. Surprisingly, the tumor can
completely invade the domain in this second phase even if the
immune response was sufficient to hold it to a steady state in the
first phase. The results of such a simulation are shown in Figure 6.
Surgical Treatment
To simulate treatment, the tumor is allowed to grow for some
specified amount of time, after which surgical excision is
performed. To simulate excision the value of all variables is set
to zero within a prescribed region. Then the simulation is allowed
to continue for several years.
The results of a surgical excision using the basic model without
an immune response are simply characterized. Immediately
following excision the wound is quickly filled by healthy cells,
and in the following absence of TAF what remains of the tumoral
vasculature quickly dies off. However, within a year any surviving
tumor cells begin invading again, and soon the tumor recovers to
pre-surgery mass.
In simulations without an immune response the tumor border is
typically sharply defined with little spread beyond the visible
border. A margin of several millimeters beyond the visible edge of
the tumor is generally sufficient to ensure no tumor cells survive.
Surgical Treatment in a Metastasizing Tumor with
Immune Response
To simulate a primary tumor seeding metastases in the nearby
tissue a normal simulation is first run for some initial amount of
time (typically 6 months). Then a very small metastasis is
introduced some distance from the primary tumor at the level of
the vasculature. Note that this metastasis is necessarily a
‘‘metastasis ring,’’ due to the symmetry of the domain. This is
not an unreasonable approximation, as metastasis spread is be
expected to be roughly symmetric, and a complete ring can be
thought to represent a worst-case scenario.
We assume that metastasis seeding can be modeled as a Poisson
process, i.e. the probability of a metastasis being created within a
given time period is an exponential random variable. We
Table 2. All immune extension parameters and values.
Parameter Meaning Value Range Reference
Dm Immune cell diffusion coefficient .000864–.071 mm
2 day
21 [42,43]
xm IC chemotaxis coefficient 1.0610
9 mm
5 g
21 day
21
bK Maximum IC death rate due to tumor cells .001–.1 IC TC
21 mm
23
lm IC density of half-maximal TC induced death 102{103 IC mm{3
bm Baseline IC turnover 0.0–.05 day
21 [46]
Da IAF diffusion coefficient Da~1:536{3:054 mm2 day{1 [37,44,45]
cac Tumor cell production of IAF 1.667610
215
21.333610
213 gT C
21 day
21 [14]
cam Maximum immune cell production of IAF 1.667610
215
21.333610
213 gT C
21 day
21
ba IAF degradation rate 2.773–16.636 day
21
cvm Maximum immune cell production of TAF 0.0–1.5610
214 gI C
21 day
21
tc0 Inactivated IC tumor cell cytotoxicity #0.218 TC IC
21 day
21 [47], see
text
tcA Fully activated IC tumor cell cytotoxicity #2.027 TC IC
21 day
21 [47], see
text
k Inherent IC bias towards debris cleanup 1.0–10.0
lc TC density of half-maximal IC cytotoxicity 10
2–10
3 TC mm
23
td0 Inactivated IC debris cleanup #0.218 TC IC
21 day
21 [47], see
text
tdA Fully activated IC debris cleanup #2.027 TC IC
21 day
21 [47], see
text
ld debris density of half-maximal IC cleanup 10
2–10
3 TC mm
23
w1 Weighs relative ability of debris to activate ICs 1.0–10.0
w2 Weighs relative ability of TCs to activate ICs 1.0–10.0
j Weighted TC density of half-maximal IC activation 10
2–10
4 TC mm
23
Qa IAF density of half maximal IC response 2:0|10{12 gm m {3
Q Maximum IC influx 1:0|105 IC mm{3 day{1
doi:10.1371/journal.pcbi.1000362.t002
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which the metastasis is seeded is exponentially distributed, with the
greatest probability next to the tumor edge. Thus, a biologically
reasonable approximation of metastatic spread into the surround-
ing skin tissue can be described by two exponential rate
parameters, lseed and ldistance.
To explicitly differentiate between primary tumor and metas-
tasis populations an additional cancer cell variable is introduced. A
number of minor modifications must be made to the model; they
are straightforward and we do not present the details.
The immune response is included in these simulations. If no
treatment is performed the primary tumor invades normally while
the metastases, if sufficiently close to the primary tumor, are
generally destroyed or held to an extremely low density. We have
found that if ldistance§1:0m m {1, then all metastases are typically
suppressed. If the primary tumor is removed, any surviving
metastases are often able to begin invading. The immune response
eventually reacts to the metastases, and the same asymptotic
behavior occurs (a steady-state is reached or the domain is
invaded). However, the metastases often increase in total mass
much more quickly than did the primary tumor. Such a course of
treatment followed by metastatic recurrence is shown in Figures 7
and 8.
Resection can lead to aggressive metastatic recurrence, but in
some cases where the immune response is very strong, resection
can lead to a state where metastases persist but remain held to a
small size. This state of persistence can last indefinitely, and an
example is shown in Figure 9.
Numerical investigation has yielded a somewhat nonintuitive
result concerning the rate at which metastases are seeded. In a
sensitivity analysis of lseed, we have found that for low values of
lseed a single secondary metastasis usually forms. Upon increasing
lseed to fairly large values, significant metastatic spread occurs, but
it is eliminated by the immune response. Very large values of lseed
cause metastatic disease to overwhelm the immune response and
invade widely. We note that the initial secondary metastasis
generally occurs at a predictable distance from the primary tumor,
just beyond the range in which the immune response directed
against the primary tumor can incidentally suppress metastases.
Figure 10 shows the results under several values of lseed.
These results suggest that moderately aggressive primary tumors
that seed many metastases can induce a widespread local immune
response that is sufficient to keep these metastases in check.
Furthermore, those metastases that do manage to grow to
significant sizes are quickly eliminated by the immune response,
even though this response cannot eliminate the primary tumor.
Discussion
We have examined the macroscopic dynamics of melanoma
tumor growth using a reaction-diffusion framework. This diffusion
framework models cell populations as a continuous density field,
Figure 3. Isosurface of tumor cells (blue), the basement membrane (gray), and endothelial cells (red) for a course of invasion using
the basic model. Time steps are evenly spaced over roughly 4.5 months of invasion. (A) An small initial tumor seed in the epidermis. (B) The tumor
has spread radially within the epidermis, and endothelial cells have begun migrating toward the tumor. (C) The basement membrane has been
penetrated by the endothelial cells, and the cancer cells have begun to invade vertically into the tumor vasculature. (D) A growing vasculature leads
the advancing edge of radial invasion. The tumor mass has penetrated to the base of the domain and the vascular bed.
doi:10.1371/journal.pcbi.1000362.g003
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tumors have an irregular and heterogeneous architecture, and
angiogenesis in particular is a spatially complex phenomenon, with
the tumor vasculature marked by irregular construction and
heterogeneity in blood flow [19]. Local perturbations and
substructures in the vasculature likely have a minimal effect on
the tumor’s overall growth and architecture.
Of more concern is the variability in nutrient supply, principally
oxygen, caused by a regionally heterogeneous vasculature, and its
potential effect on overall tumor growth. However, our model
suggests that melanoma is rather unique among solid tumors, with
significant hypoxia only occurring at the leading edge of invasion.
This is due in large part to the significant amounts of oxygen
diffusing into the tumor core from the skin surface. Thus, the
unique geometry in which melanoma invades likely dampens the
importance of vascular irregularity. Therefore, we argue that the
diffusion approximation can reasonably be employed in examining
melanoma tumor invasion at the macroscopic level.
Using this model as a framework for early investigation, we have
observed a wide range of interesting and biologically reasonable
patterns of tumor invasion. Angiogenesis is strongly tumorigenic in
this model. In simulations using the basic model, following the onset
of angiogenesis the tumor spreads throughout the dermis and a
significant necrotic core forms. Hypoxia is always most severe at the
leading edge of radial invasion, and the necrotic core expands as an
annulus in sustained invasion. The constitutive production of TAF
(particularly VEGF) is more important than production in response
to hypoxia in inducing angiogenesis in melanomas. In simulations,
even the most aggressive cancer cell strains are unable to induce
angiogenesis without at least a low level of constitutive TAF
Figure 5. 1-D projection of variables densities at the inner radius of the domain. Time steps are evenly spaced over roughly 4.5 months of
invasion under the basic model. (A) The seed of a tumor has been planted at the base of the epidermis. (B) The tumor has expanded vertically into the
upper epidermis, and has increased in density due to cancer cells out-competing the healthy cells. (C) Here, the basement membrane has been
eliminated, and the tumor invades vertically into the existing tumor-associated vasculature. (D) A significant necrotic core has formed roughly in the
center of the vertical domain, very few healthy cells remain, and cancer cells continue to grow into the tumor vasculature.
doi:10.1371/journal.pcbi.1000362.g005
Figure 4. 2-D projection of all variables, with the exception of TAF, at three time steps over the course of 6 months of invasion
under the basic model. (A) The normal skin is largely intact, but a small epidermal tumor has displaced some of the surrounding healthy cells. (B)
The tumor mass has been penetrated by the endothelial cells and, because of the associated degradation of the basement membrane, is invading
vertically. The tumor is somewhat hypoxic, a core of necrotic debris has begun to form, and healthy cells continue to be displaced by the tumor. (C) A
large tumor has invaded to the base of the domain and continues to expand radially. Hypoxia is most severe at the edge of invasion; this is reflected
by the annular expansion of the necrotic core.
doi:10.1371/journal.pcbi.1000362.g004
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melanomas or by cooperating stromal cells.
When an immune response is considered, it usually inhibits
tumor growth, often destroying invasive tumors or holding them at
a steady state for many years. These outcomes are observed in
biologically reasonable parameter space, implying the immune
response often plays a clinically meaningful role in the control of
cancer growth. However, immune cells expressing TAF can also
aid melanoma invasion by inducing tumorigenic angiogenesis.
This can lead to a qualitative change in tumor behavior as non-
invasive melanoma tumors restricted to the epidermis become
aggressively invasive following immune induced angiogenesis.
We have investigated a primary tumor seeding micro-metastases
into the local skin tissue. This line investigation is motivated by the
Figure 6. Two-phase pattern of invasion where the immune system holds tumor growth to an initial steady state in the epidermis.
This steady state persists for about 300 days, but the expression of angiogenic factors by activated immune cells induces angiogenesis that leads to
aggressive, unchecked tumor invasion.
doi:10.1371/journal.pcbi.1000362.g006
Figure 7. Resection followed by metastatic recurrence. The primary tumor is held to a steady state and metastases are present at undetectable
levels prior to resection. Following resection, aggressive metastatic recurrence occurs. The asymptotic behavior of the metastases is the same as the
primary tumor (i.e. steady state), but the overall growth rate is faster, and the final cancer load is much greater.
doi:10.1371/journal.pcbi.1000362.g007
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presented with a large polypoid melanoma lesion that had
reportedly been growing slowly for about three years. Following
resection there was rapid recurrence in a number of previously
dormant satellite metastases within 5–7 cm of the original lesion.
This case was previously examined in a mathematical model of
tumor dormancy by Boushaba et al. [16]. This is not an isolated
case, as many cases of local melanoma recurrence are actually
caused by local micro-metastases and not by incomplete resection
of the primary tumor [15].
We propose that local metastatic spread can be reasonably
modeled using two exponential rate parameters. The first, lseed,
gives the rate at which micrometastases shed from the primary
tumor into the circulation. The second, ldistance, determines the
distance from the primary tumor at which extravasation occurs.
Under this model, simulations have suggested that moderately
Figure 8. Isosurfaces of a metastatic primary tumor before and after resection. Primary tumor (blue), metastases (cyan), and the basement
membrane (gray) are shown. (A) The primary tumor at a steady state along with suppressed metastases. The exact picture shown is representative of
the fluctuating metastatic load, which varies somewhat, although the overall behavior is one of a quasi-steady state. (B) Metastatic recurrence 6
months after resection of the primary tumor. The resection was successful in removing all material from the primary tumor, but the total mass of the
metastases already exceeds that of the primary tumor.
doi:10.1371/journal.pcbi.1000362.g008
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optimal for the suppression of metastatic disease. Melanomas that
seed metastases only occasionally do not induce sufficient immune
activity to destroy metastases beyond a threshold distance, while
extremely metastatic melanomas overwhelm the immune re-
sponse.
This framework also suggests an explanation for the phenom-
enon of aggressive metastasis growth following surgical excision of
a primary tumor. The immune response directed against a
primary tumor can suppress nearby metastases. Following surgical
excision most of the immune cells attacking the primary tumor are
removed, as is the major source of cytokines attracting other
immune cells to the sight. In the absence of this immune response,
previously checked metastases can begin growing aggressively.
The total mass and growth rate of these metastases can exceed that
of the primary lesion, making this recurrence potentially more
clinically dangerous. This phenomenon was also studied in a
mathematical model by Boushaba et al. [16] who found that the
release of growth inhibiting cytokines produced by the primary
tumor is a possible mechanism. Anti-angiogenic factors released by
the primary tumor, such as angiostatin and endostatin, are another
major explanation [17]. Metastasis suppression by these factors
and the immune response are not mutually exclusive hypotheses,
and all may play a role.
There is clearly a threshold distance beyond which local
immune activation is insufficient to suppress metastases. This
distance may be highest in moderately metastatic tumors. It is
possible that immune activation plays the dominant role in
suppression near the primary tumor, where most metastases are
expected to extravasate. Further away, growth inhibition due to
soluble factors may become dominant. However, our model has
not taken into account circulating lymphocytes or antibodies that
may play an important role. Despite its limitations, the overall
implication of this work is that therapy targeting a primary tumor
can perturb the host immune response in a way that allows
increased growth in disseminated disease without altering any of
the underlying parameters describing the system.
The full model framework presented here can be translated
into more focused systems aimed at addressing specific questions
concerning melanoma invasion and treatment. With our model
we have demonstrated that disruption of the immune response
caused by surgical excision of a primary tumor is a possible
mechanism for increased metastasis growth. Following surgery
the wound healing response and associated inflammatory
response probably also plays a role in cancer recurrence. A
more detailed examination of tumor excision with a wound
healing cascade could give insight into the importance of
immune disruption. The effects of additional treatments such as
chemotherapy or radiation therapy on the immune response and
metastasis growth should also be investigated. Mathematical
modeling may be particularly suited to examining the effect of
different treatment schedules. At the least, predictions could be
made concerning the efficacy of pre- versus post-operative
adjuvant therapy.
Finally, this framework provides an opportunity to investigate
the nature and power of the natural selective forces at work driving
the evolution of aggressive melanoma tumors. By incorporating
multiple cell strains with differential parameter values, we can
study the spatial and temporal requirements for successful mutant
strain invasion of a pre-existing tumor and how allopathic
intervention alters the balance of selective forces in and around
the primary tumor.
Figure 9. Resection of a strongly immunogenic tumor followed by low-level metastatic persistence. In this case, the immune response
holds the metastatic load to a total mass much less than that of the primary tumor, and unlike in the cases shown in Figures 7 and 8, resection of the
primary tumor does not induce growth in these metastases. However, a small but biologically relevant metastatic load remains, suggesting that
dormant metastases can persist nearly indefinitely and may be sensitive to future perturbations of the system.
doi:10.1371/journal.pcbi.1000362.g009
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